ISSN 1662-4009 (online)

ey0016.7-16 | Treatment | ESPEYB16

7.16. Toward more targeted and cost-effective gonadotropin-releasing hormone analog treatment in girls with central precocious puberty

PB Kaplowitz , PF Backeljauw , DB Allen

To read the full abstract: Horm Res Paediatr. 2018;90(1):1–7.The authors discuss why GnRH analog therapies should not be used in all girls with central precocious puberty (CPP), but only in those cases where the predicted benefits outweigh the risks and high cost of the treatment.Epidemiological studies in Europe and USA show declining average a...

ey0016.4-10 | New Perspectives | ESPEYB16

4.10. Associations of protein intake in early childhood with body composition, height, and insulin-like growth factor I in mid-childhood and early adolescence

KM Switkowski , PF Jacques , A Must , A Fleisch , E Oken

To read the full abstract: Am J Clin Nutr. 2019;109:1154–1163.Early life nutrition has long-term effects on body composition and obesity risk. Breastfed infants have a lower risk of obesity, which may be related to the lower protein intake in human milk compared to infant formula. Recent studies have confirmed the association between high-protein intake during the first years of lif...

ey0017.4-2 | Important for clinical practice | ESPEYB17

4.2. Genetic disorders in prenatal onset syndromic short stature identified by exome sequencing

TK Homma , BL Freire , RS Honjo Kawahira , A Dauber , MFA Funari , AM Lerario , MY Nishi , EV Albuquerque , GA Vasques , PF Collett-Solberg , SM Miura Sugayama , DR Bertola , CA Kim , IJP Arnhold , AC Malaquias , AAL Jorge

To read the full abstract: J Pediatr. 2019 Dec;215:192–198.Identifying the diagnosis in children with syndromic short stature and those with recognized genetic growth disorders is often challenging, as they may share many clinical features (1)(2). The candidate gene approach has many limitations in unveiling the genetic cause. Therefore, whole exome sequencing (WES) has been proposed to improve the diagnostic rate in children with short sta...

ey0017.4-1 | Important for clinical practice | ESPEYB17

4.1. Diagnosis, genetics, and therapy of short stature in children: A growth hormone research society international perspective

PF Collett-Solberg , G Ambler , PF Backeljauw , M Bidlingmaier , BMK Biller , MCS Boguszewski , PT Cheung , CSY Choong , LE Cohen , P Cohen , A Dauber , CL Deal , C Gong , Y Hasegawa , AR Hoffman , PL Hofman , R Horikawa , AAL Jorge , A Juul , P Kamenicky , V Khadilkar , JJ Kopchick , B Kristrom , MdLA Lopes , X Luo , BS Miller , M Misra , I Netchine , S Radovick , MB Ranke , AD Rogol , RG Rosenfeld , P Saenger , JM Wit , J Woelfle

To read the full abstract: Horm Res Paediatr. 2019;92:1–14In March 2019, 46 international experts from 14 countries across 5 continents attended a 3-day workshop organized by the Growth Hormone Research Society (GRS) and produced this perspective on the diagnosis, management and therapy in children with short stature. In this context, this expert panel tackled almost all aspects related to the management of children with short stature, prov...

ey0017.2-3 | Neonatal Hypoglycaemia | ESPEYB17

2.3. Lower versus traditional treatment threshold for neonatal hypoglycemia

AAMW van Kempen , PF Eskes , DHGM1 Nuytemans , JH van der Lee , LM Dijksman , NR van Veenendaal , FJPCM van der Hulst , RMJ Moonen , LJI Zimmermann , EP van’t Verlaat , Baal M van Dongen-van , BA Semmekrot , HG Stas , RHT van Beek , JJ Vlietman , PH Dijk , JUM Termote , RCJ de Jonge , AC de Mol , MWA Huysman , JH Kok , M Offringa , N; HypoEXIT Study Group Boluyt

To read the full abstract: N Engl J Med. 2020 Feb 6;382(6):534–544. PMID: 32023373Neonatal hypoglycaemia is one of the most common biochemical findings in the newborn period and is an important cause of brain injury. However, despite being so common there is no consensus regarding the glucose threshold concentration at which treatment for asymptomatic neonatal hypoglycemia sho...